This Article Full Text Full Text (PDF) All Versions of this Article: 111/7/871    most recent 01.CIR.0000155621.10213.06v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chhokar, V. S. Articles by Weber, K. T. Search for Related Content PubMed PubMed Citation Articles by Chhokar, V. S. Articles by Weber, K. T. Related Collections Cardio-renal physiology/pathophysiology Animal models of human disease Oxidant stress Related Article

(Circulation. 2005;111:871-878.)
© 2005 American Heart Association, Inc.

Heart Failure

Hyperparathyroidism and the Calcium Paradox of Aldosteronism

Vikram S. Chhokar, MD; Yao Sun, MD, PhD; Syamal K. Bhattacharya, PhD; Robert A. Ahokas, PhD; Linda K. Myers, MD; Zhiqing Xing, MD, PhD; Richard A. Smith, PhD; Ivan C. Gerling, PhD; Karl T. Weber, MD

From the Divisions of Cardiovascular Diseases (V.S.C., Y.S., K.T.W.) and Endocrinology (I.C.G.), Department of Medicine, and Departments of Surgery (S.K.B.), Obstetrics and Gynecology (R.A.A.), Pediatrics (L.K.M.), and Orthopaedic Surgery (Z.X., R.A.S.), University of Tennessee Health Science Center, Memphis.

Correspondence to Karl T. Weber, MD, Division of Cardiovascular Diseases, University of Tennessee Health Science Center, 920 Madison Ave, Ste 300, Memphis, TN 38163. E-mail KTWeber{at}utmem.edu

Received October 6, 2004; revision received November 5, 2004; accepted November 10, 2004.

Background— Aldosteronism may account for oxi/nitrosative stress, a proinflammatory phenotype, and wasting in congestive heart failure. We hypothesized that aldosterone/1% NaCl treatment (ALDOST) in rats enhances Ca²⁺ and Mg²⁺ excretion and leads to systemic effects, including bone loss.

Methods and Results— At 1, 2, 4, and 6 weeks of ALDOST, we monitored Ca²⁺ and Mg²⁺ excretion, ionized [Ca²⁺]_o and [Mg²⁺]_o, parathyroid hormone and ₁-antiproteinase activity in plasma, bone mineral density, bone strength, Ca²⁺ and Mg²⁺ content in peripheral blood mononuclear cells (PBMCs) and ventricular tissue, and lymphocyte H₂O₂ production. A separate group received spironolactone (Spiro), an aldosterone receptor antagonist. Age- and gender-matched unoperated and untreated rats served as controls. ALDOST induced a marked (P<0.05) and persistent rise in urinary and fecal Ca²⁺ and Mg²⁺ excretion, a progressive reduction (P<0.05) in [Ca²⁺]_o and [Mg²⁺]_o, and an elevation in parathyroid hormone (P<0.05) with a fall (P<0.05) in bone mineral density and strength. An early, sustained increase (P<0.05) in PBMC Ca²⁺ and Mg²⁺ was found, together with an increase (P<0.05) in tissue Ca²⁺. Plasma ₁-antiproteinase activity was reduced (P<0.05), whereas lymphocyte H₂O₂ production was increased (P<0.05) at all time points. Spiro cotreatment attenuated (P<0.05) urinary and fecal Ca²⁺ and Mg²⁺ excretion, prevented the fall in [Ca²⁺]_o and [Mg²⁺]_o, rescued bone mineral density and strength, and prevented Ca²⁺ overloading of PBMCs and cardiomyocytes.

Conclusions— In aldosteronism, Ca²⁺ and Mg²⁺ losses lead to a fall in [Ca²⁺]_o and [Mg²⁺]_o with secondary hyperparathyroidism and bone resorption. Ca²⁺ overloading of PBMCs and cardiac tissue leads to oxi/nitrosative stress and a proinflammatory phenotype.

Key Words: aldosterone • calcium • magnesium • osteoporosis • parathyroid hormone

Related Article:

Calcium, Magnesium, and Oxidative Stress in Hyperaldosteronism

Ernesto L. Schiffrin and Rhian M. Touyz
Circulation 2005 111: 830-831. [Extract] [Full Text]

This article has been cited by other articles:

				S. van Diepen, S. R. Majumdar, J. A. Bakal, F. A. McAlister, and J. A. Ezekowitz Heart Failure Is a Risk Factor for Orthopedic Fracture: A Population-Based Analysis of 16 294 Patients Circulation, November 4, 2008; 118(19): 1946 - 1952. [Abstract] [Full Text] [PDF]

				D. E. Wallis, S. Penckofer, and G. W. Sizemore The "Sunshine Deficit" and Cardiovascular Disease Circulation, September 30, 2008; 118(14): 1476 - 1485. [Full Text] [PDF]

				L. D. Carbone, J. D. Cross, S. H. Raza, A. J. Bush, R. J. Sepanski, S. Dhawan, B. Q. Khan, M. Gupta, K. Ahmad, R. N. Khouzam, et al. Fracture Risk in Men With Congestive Heart Failure: Risk Reduction With Spironolactone J. Am. Coll. Cardiol., July 8, 2008; 52(2): 135 - 138. [Abstract] [Full Text] [PDF]

				K. T Weber, R. U Simpson, and L. D Carbone Vitamin D and calcium dyshomoeostasis-associated heart failure Heart, May 1, 2008; 94(5): 540 - 541. [Full Text] [PDF]

				B. Sontia, A. C.I. Montezano, T. Paravicini, F. Tabet, and R. M. Touyz Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium Hypertension, April 1, 2008; 51(4): 915 - 921. [Abstract] [Full Text] [PDF]

				J. Varagic, E. D. Frohlich, D. Susic, J. Ahn, L. Matavelli, B. Lopez, and J. Diez AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H853 - H858. [Abstract] [Full Text] [PDF]

				S. Alsafwah, S. P. LaGuardia, M. Arroyo, B. K. Dockery, S. K. Bhattacharya, R. A. Ahokas, and K. P. Newman Congestive Heart Failure is a Systemic Illness: A Role for Minerals and Micronutrients Clin. Med. Res., December 1, 2007; 5(4): 238 - 243. [Abstract] [Full Text] [PDF]

				M. Thomas, A. Vidal, S. K. Bhattacharya, R. A. Ahokas, Y. Sun, I. C. Gerling, and K. T. Weber Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2361 - H2366. [Abstract] [Full Text] [PDF]

				Y. Sun, R. A. Ahokas, S. K. Bhattacharya, I. C. Gerling, L. D. Carbone, and K. T. Weber Oxidative stress in aldosteronism Cardiovasc Res, July 15, 2006; 71(2): 300 - 309. [Abstract] [Full Text] [PDF]

				A. Vidal, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, I. C. Gerling, and K. T. Weber Calcium paradox of aldosteronism and the role of the parathyroid glands Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H286 - H294. [Abstract] [Full Text] [PDF]

				M. Stowasser, J. Sharman, R. Leano, R. D. Gordon, G. Ward, D. Cowley, and T. H. Marwick Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5070 - 5076. [Abstract] [Full Text] [PDF]

				P. H. Law, Y. Sun, S. K. Bhattacharya, V. S. Chhokar, and K. T. Weber Diuretics and Bone Loss in Rats With Aldosteronism J. Am. Coll. Cardiol., July 5, 2005; 46(1): 142 - 146. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin and R. M. Touyz Calcium, Magnesium, and Oxidative Stress in Hyperaldosteronism Circulation, February 22, 2005; 111(7): 830 - 831. [Full Text] [PDF]